Skip to content

Edwards Certitude Delivery System 9630TA29Recalls & reported problems

Edwards Lifesciences LLC · Edwards Certitude Delivery System · Class 3

All models of Edwards Certitude Delivery System (7)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00690103201451), received between Mar 29, 2021 and Feb 21, 2025 — classified as 2 injuries, 2 malfunctions.

The most frequently reported specific device problem is “Burst Container or Vessel” (2 reports).

3 other recalls cover devices cleared under the same FDA submission (P140031); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 1 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Burst Container or Vessel2
  • Adverse Event Without Identified Device or Use Problem1
  • Difficult to Advance1
  • Difficult to Remove1
  • Material Separation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions4

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 21, 2025Burst Container or Vessel; Difficult to Remove; Material Separation; Burst Container or Vessel; Difficult to Remove; Material Separation

    AS REPORTED BY THE FIELD CLINICAL SPECIALIST (FCS), DURING AN INNOMINATE ARTERY TAVR PROCEDURE WITH A 29MM SAPIEN 3 VALVE, THE CERTITUDE DELIVERY SYSTEM BALLOON RUPTURED TOWARDS THE END OF DEPLOYMENT. PER TEE, THE VALVE WAS WELL DEPLOYED WITH NO LEAKAGE, SO THE TEAM ATTEMPTED TO BRING THE DELIVERY SYSTEM BACK INTO THE SHEATH, HOWEVER RESISTANCE WAS MET. AFTER MULTIPLE MANEUVERS, THE FRONT NOSE CONE AND DISTAL PORTION OF THE BALLOON BECAME DETACHED FROM THE REST OF THE DELIVERY SYSTEM. THE TEAM ELECTED TO TRY TO SNARE THE REMAINING PART OF THE SYSTEM WHILE ON THE WIRE, BUT WAS UNABLE TO AFTER MULTIPLE ATTEMPTS. SO THE TEAM ELECTED TO ATTEMPT SNARING THE REMAINING PARTS OF THE SYSTEM VIA FEMORAL ACCESS WITH A 22FR DRYSEAL. THIS ATTEMPT WAS SUCCESSFUL. ANGIOS AND TEE WERE PERFORMED, AND THE TEAM FELT THEY DIDN'T SEE ANY INJURY TO THE PATIENT. THE PATIENT WAS TRANSFUSED DUE TO BLOOD LOSS. PER REPORT, THE PATIENT REMAINED STABLE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21435675 ↗
  • MalfunctionDec 23, 2021Burst Container or Vessel; Burst Container or Vessel

    EDWARDS RECEIVED NOTIFICATION FROM A FIELD CLINICAL SPECIALIST THAT DURING A TRANSAPICAL TAVR IN AN UNKNOWN SURGICAL VALVE THE CERTITUDE DELIVERY SYSTEM BALLOON RUPTURED AFTER THE 29 SAPIEN 3 VALVE WAS FULLY INFLATED. AS REPORTED, THERE WAS A CHUNK OF CALCIUM IN ANNULUS. A BALLOON AORTIC VALVULOPLASTY WAS NOT PERFORMED. THERE WAS NO EXTRA VOLUME ADDED TO THE BALLOON PRIOR TO THE INFLATION. THE INFLATION TECHNIQUE WAS SLOW. NOMINAL VOLUME WAS USED FOR INFLATION. A LONGITUDINAL AND LATERAL TEAR OF BALLOON WAS OVERSERVED. THE DELIVERY SYSTEM WAS SAFELY REMOVED AND THERE WAS NO HARM TO THE LV. THERE WERE NO NEGATIVE OUTCOMES OR PATIENT INJURIES. THE DEVICE IS NOT AVAILABLE FOR RETURN.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 13078471 ↗
  • MalfunctionSep 2, 2021Difficult to Advance; Difficult to Advance

    DIFFICULTIES WERE ENCOUNTERED CROSSING A PRE-EXISTING TRICUSPID SURGICAL VALVE DURING A VALVE IN VALVE (VIV) PROCEDURE. DIFFICULTIES WERE ALSO ENCOUNTERED DURING THE WITHDRAWAL OF THE CERTITUDE DELIVERY SYSTEM, RESULTING IN MOVEMENT OF A SAPIEN 3 VALVE ON THE DELIVERY SYSTEM BALLOON. DURING AN OFF-LABEL TRANS-JUGULAR TRICUSPID VIV PROCEDURE, A 29MM SAPIEN 3 VALVE AND CERTITUDE DELIVERY SYSTEM WOULD NOT CROSS THE PRE-EXISTING SURGICAL VALVE. THE DECISION WAS MADE TO PERFORM A BALLOON VALVULOPLASTY. DIFFICULTIES WERE ENCOUNTERED DURING THE WITHDRAWAL OF THE DELIVERY SYSTEM AND VALVE. THE VALVE COULD NOT BE PULLED INTO THE 21FR SHEATH AND WAS PUSHED 4MM TOWARD THE NOSE CONE. THE VALVE WAS SUCCESSFULLY DEPLOYED IN THE SUPERIOR VENA CAVA (SVC). THE PROCEDURE WAS THEN CONVERTED TO THE TRANSFEMORAL APPROACH. A NEW VALVE AND COMMANDER DELIVERY SYSTEM WERE PREPARED. FOLLOWING BALLOON VALVULOPLASTY, THE NEW SAPIEN 3 VALVE WAS SUCCESSFULLY DEPLOYED IN THE PRE-EXISTING TRICUSPID SURGICAL VALVE. THE PATIENT WAS STABLE THROUGHOUT THE PROCEDURE. AT THE TIME OF THE REPORT, THE PATIENT WAS IN STABLE CONDITION. ALL VALVES REMAIN IMPLANTED IN THE PATIENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12418274 ↗
  • InjuryMar 29, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    EDWARDS RECEIVED NOTIFICATION FROM AN FIELD CLINICAL SPECIALIST THAT AN SAPIEN 3 VALVE WAS STRIPPED OFF THE DELIVERY SYSTEM AND EMBOLIZED INTO THE LEFT VENTRICULAR OUTFLOW TRACT(LVOT). AS REPORTED, THIS PATIENT WAS A TA APPROACH DUE TO SIGNIFICANT CALCIUM BURDEN AT THE OTHER ALTERNATE ACCESS SITES. THERE WAS A HEAVY CALCIUM BURDEN AT THE LVOT. DURING THE TA APPROACH WITH THE CERTITUDE DELIVERY SYSTEM, THE PHYSICIANS FELT THAT THE VALVE GOT CAUGHT ON THE LVOT CALCIUM. WHEN THE PHYSICIAN TRIED TO PULL BACK THE SYSTEM AND REPOSITION IT, THE VALVE WAS STRIPPED OFF THE DELIVERY SYSTEM AND EMBOLIZED INTO THE LV. EMERGENT ECMO WAS INITIATED. THE PHYSICIAN WAS ABLE TO RETRIEVE THE EMBOLIZED VALVE THROUGH THE TA INCISION AND A NEW SHEATH, CERTITUDE DELIVERY SYSTEM AND VALVE WERE USED TO COMPLETE THIS PROCEDURE. THE PATIENT REMAINED UNDER CRITICAL OBSERVATION IN THE CCU. THE LAST KNOWN STATUS IS THAT PATIENT IS DOING WELL.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11586715 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P140031. One submission often covers many models, so check the product and lot details in each record.

  • Z-0835-2019 · Jan 22, 2019 · Terminated
    Edward Lifesciences, Edwards Commander Delivery System: Model Number UDI Number 9600LDS20A (US) 00690103193930 9600LDS20J 00690103194852 9600LDS23A (US) 00690103193947 9600LDS23J 0
  • Z-2435-2018 · Jun 11, 2018 · Terminated
    Edwards SAPIEN 3 Transcatheter Heart Valve (THV), Model: 9600TFX, Size: 26 mm
  • Z-0293-2018 · Jul 21, 2017 · Terminated
    Certitude Delivery System and any associated Multipacks Models - 9600CT20A, 9600CT23A, 9600CT26A, 9600CT29A Product Usage: The Edwards Certitude Delivery System is used for delive

Other Prosthesis, Mitral Valve, Percutaneously Delivered devices

All Prosthesis, Mitral Valve, Percutaneously Delivered devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page